Daily application of mechanical insufflation-exsufflation (MI-E) is used increasingly in patients with neuromuscular diseases (NMDs) to prevent pulmonary congestion and thereby respiratory tract infections, although its beneficial effect remains uncertain. We, therefore, conducted a systematic review, registered in PROSPERO (CRD42020158278), to compile available evidence for daily MI-E use in subjects with NMDs and stable respiratory condition.
METHODS:
We performed a systematic comprehensive search of MEDLINE, Embase, CINAHL, and Web of Science up to December 23, 2021. We excluded articles studying the effect of MI-E in case of acute respiratory failure or infections and studies comparing different MI-E devices and settings. Studied outcomes were prevalence and severity of respiratory infections, lung function, respiratory characteristics, and patient satisfaction. We performed a meta-analysis using DerSimonian-Laird random effects model and assessed methodological quality by using the Alberta Heritage Foundation for Medical Research tool.
RESULTS:
A total of 3,374 records were screened, of which 25 were included, studying 608 subjects. One randomized controlled trial (RCT) found a trend toward reduced duration of respiratory infections compared to air stacking (AS) that was not statistically significant. Long-term effects on pulmonary function tests (PFT) results were reported in one RCT and one retrospective study, with mixed results regarding vital capacity. Most studies compared PFT results before and immediately after MI-E use. Meta-analysis showed an overall beneficial effect of MI-E on cough peak flow (CPF) compared to unassisted CPF (mean difference 91.6 L/min [95% CI 28.3–155.0], P < .001). Subject satisfaction was high, though possibly influenced by major bias.
CONCLUSIONS:
There is limited evidence available to support beneficial effects of daily use of MI-E in clinically stable subjects with NMDs, with the possible exception of increased CPF immediately after MI-E application. Lack of longitudinal studies preclude conclusions regarding long-term effects. The very limited data comparing MI-E to AS preclude comparisons.
BoitanoLJ. Management of airway clearance in neuromuscular disease. Respir Care, 2006; 51(8):913-922.
2.
ChatwinM, ToussaintM, GonçalvesMR, SheersN, MelliesU, Gonzales-BermejoJ, et al. Airway clearance techniques in neuromuscular disorders: a state of the art review. Respir Med, 2018; 136:98-110.
3.
AndrewsJG, SoimA, PandyaS, WestfieldCP, CiafaloniE, FoxDJ, et al. on behalf of Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet). Respiratory care received by individuals with Duchenne muscular dystrophy from 2000 to 2011. Respir Care, 2016; 61(10):1349-1359.
4.
TzengAC, BachJR. Prevention of pulmonary morbidity for patients with neuromuscular disease. Chest, 2000; 118(5):1390-1396.
5.
BirnkrantDJ, BushbyK, BannCM, AlmanBA, ApkonSD, BlackwellA, et al. on behalf of DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol, 2018; 17(4):347-361.
6.
FinkelRS, MercuriE, MeyerOH, SimondsAK, SchrothMK, GrahamRJ, et al. on behalf of SMA Care group. Diagnosis and management of spinal muscular atrophy: part 2: pulmonary and acute care; medications, supplements, and immunizations; other organ systems; and ethics. Neuromuscul Disord, 2018; 28(3):197-207.
7.
HullJ, AniapravanR, ChanE, ChatwinM, FortonJ, GallagherJ, et al. British Thoracic Society guideline for respiratory management of children with neuromuscular disease. Thorax, 2012; 67(Suppl 1):i1-40.
8.
ChatwinM, RossE, HartN, NickolAH, PolkeyMI, SimondsAK. Cough augmentation with mechanical insufflation-exsufflation in patients with neuromuscular weakness. Eur Respir J, 2003; 21(3):502-508.
9.
SatoT, MurakamiT, IshiguroK, ShichijiM, SaitoK, OsawaM, et al. Respiratory management of patients with Fukuyama congenital muscular dystrophy. Brain Dev, 2016; 38(3):324-330.
10.
MorrowB, ArgentA, ZampoliM, HumanA, CortenL, ToussaintM. Cough augmentation techniques for people with chronic neuromuscular disorders. Cochrane Database Syst Rev, 2021; 4(4):CD013170.
11.
ToussaintM, ChatwinM, GonzalesJ, BerlowitzDJ, ToussaintM, ChatwinM, et al. ENMC Respiratory Therapy Consortium. 228th ENMC International Workshop: airway clearance techniques in neuromuscular disorders Naarden, the Netherlands, 3–5 Mar, 2017. Neuromuscul Disord, 2018; 28(3):289-298.
12.
PageMJ, McKenzieJE, BossuytPM, BoutronI, HoffmannTC, MulrowCD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 2021; 372:n71.
13.
WanX, WangW, LiuJ, TongT. Estimating the sample mean and standard deviation from the sample size, median, range, and/or interquartile range. BMC Med Res Methodol, 2014; 14:135.
14.
AndersenT, SandnesA, BrekkaAK, HillandM, ClemmH, FondenesO, et al. Laryngeal response patterns influence the efficacy of mechanical assisted cough in amyotrophic lateral sclerosis. Thorax, 2017; 72(3):221-229.
15.
AndersenTM, SandnesA, FondenesO, NilsenRM, TysnesO-B, HeimdalJ-H, et al. Laryngeal responses to mechanically assisted cough in progressing amyotrophic lateral sclerosis. Respir Care, 2018; 63(5):538-549.
16.
MericH, FalaizeL, PradonD, LacombeM, PetitjeanM, OrlikowskiD, et al. Short-term effect of volume recruitment-derecruitment maneuvers on chest-wall motion in Duchenne muscular dystrophy. Chron Respir Dis, 2017; 14(2):110-116.
17.
MiskeLJ, HickeyEM, KolbSM, WeinerDJ, PanitchHB. Use of the mechanical in-exsufflator in pediatric patients with neuromuscular disease and impaired cough. Chest, 2004; 125(4):1406-1412.
18.
MoranFC, SpittleAJ, DelanyC. Lifestyle implications of home mechanical insufflation-exsufflation for children with neuromuscular disease and their families. Respir Care, 2015; 60(7):967-974.
19.
MoranFCE, SpittleA, DelanyC, RobertsonCF, MassieJ. Effect of home mechanical in-exsufflation on hospitalization and lifestyle in neuromuscular disease: a pilot study. J Paediatr Child Health, 2013; 49(3):233-237.
20.
MustfaN, AielloM, LyallRA, NikoletouD, OlivieriD, LeighPN, et al. Cough augmentation in amyotrophic lateral sclerosis. Neurology, 2003; 61(9):1285-1287.
21.
RafiqMK, BradburnM, ProctorAR, BillingsCG, BianchiS, McdermottCJ, ShawPJ. A preliminary randomized trial of the mechanical insufflator-exsufflator versus breath-stacking technique in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener, 2015; 16(7-8):448-455.
22.
SanchoJ, ServeraE, DíazJ, MarínJ. Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis. Chest, 2004; 125(4):1400-1405.
23.
SantosDB, BoréA, CastrilloLDA, LacombeM, FalaizeL, OrlikowskiD, et al. Assisted vital capacity to assess recruitment level in neuromuscular diseases. Respir Physiol Neurobiol, 2017; 243:32-38.
24.
SenentC, GolmardJL, SalachasF, ChinerE, Morelot-PanziniC, MeningerV, et al. A comparison of assisted cough techniques in stable patients with severe respiratory insufficiency due to amyotrophic lateral sclerosis. Amyotroph Lateral Scler, 2011; 12(1):26-32.
25.
SiewersV, HolmoyT, FrichJC. Experiences with using mechanical in-exsufflation in amyotrophic lateral sclerosis. Eur J Physiother, 2013; 15(4):201-207.
26.
BachJR. Mechanical insufflation-exsufflation: comparison of peak expiratory flows with manually assisted and unassisted coughing techniques. Chest, 1993; 104(5):1553-1562.
27.
SivasothyP, BrownL, SmithIE, ShneersonJM. Effect of manually assisted cough and mechanical insufflation on cough flow of normal subjects, patients with chronic obstructive pulmonary disease (COPD), and patients with respiratory muscle weakness. Thorax, 2001; 56(6):438-444.
TravlosV, DrewK, PatmanS. The value of the CoughAssist in the daily lives of children with neuromuscular disorders: experiences of families, children, and physiotherapists. Dev Neurorehabil, 2016; 19(5):321-326.
30.
VeldhoenES, Verweij-van den OudenrijnLP, RosLA, HulzebosEH, PapazovaDA, van der EntCK, et al. Effect of mechanical insufflation-exsufflation in children with neuromuscular weakness. Pediatr Pulmonol, 2020; 55(2):510-513.
31.
WinckJC, GonçalvesMR, LourençoC, VianaP, AlmeidaJ, BachJR. Effects of mechanical insufflation-exsufflation on respiratory parameters for patients with chronic airway secretion encumbrance. Chest, 2004; 126(3):774-780.
32.
CesareoA, LoMauroA, SantiM, BiffiE, D’AngeloMG, AlivertiA. Acute effects of mechanical insufflation-exsufflation on the breathing pattern in stable subjects with Duchenne muscular dystrophy. Respir Care, 2018; 63(8):955-965.
33.
FaurouxB, GuillemotN, AubertinG, NathanN, LabitA, ClémentA, LofasoF. Physiologic benefits of mechanical insufflation-exsufflation in children with neuromuscular diseases. Chest, 2008; 133(1):161-168.
34.
KimSM, ChoiWA, WonYH, KangSW. A comparison of cough assistance techniques in patients with respiratory muscle weakness. Yonsei Med J, 2016; 57(6):1488-1493.
35.
LacombeM, Del Amo CastrilloL, BoréA, ChapeauD, HorvatE, VaugierI, et al. Comparison of three cough-augmentation techniques in neuromuscular patients: mechanical insufflation combined with manually assisted cough, insufflation-exsufflation alone, and insufflation-exsufflation combined with manually assisted cough. Respiration, 2014; 88(3):215-222.
36.
LalmoldaC, PradosH, MateuG, NorayM, PomaresX, LujánM. Titration of mechanical insufflation-exsufflation optimal pressure combinations in neuromuscular diseases by flow/pressure waveform analysis. Arch Bronconeumol (Engl Ed), 2019; 55(5):246-251.
37.
MahedeT, DavisG, RutkayA, BaxendaleS, SunW, DawkinsHJS, et al. Use of mechanical airway clearance devices in the home by people with neuromuscular disorders: effects on health service use and lifestyle benefits. Orphanet J Rare Dis, 2015; 10:54.
38.
DobkinC, FinkelsteinA, KluenderR, NotowidigdoMJ. The economic consequences of hospital admissions. Am Econ Rev, 2018; 102(2):308-352.
39.
RennickJE, DoughertyG, ChambersC, StremlerR, ChilderhoseJE, StackDM, et al. Children’s psychological and behavioral responses following pediatric intensive care unit hospitalization: the caring intensively study. BMC Pediatr, 2014; 14(276).
40.
RokachA. Psychological, emotional, and physical experiences of hospitalized children. Clin Case Reports Rev, 2016; 2(4):399-401.
41.
VeldhoenES, VercoelenF, RosL, Verweij-van den OudenrijnLP, Wösten-van AsperenRM, HulzebosEHJ, et al. Short-term effect of air stacking and mechanical insufflation-exsufflation on lung function in patients with neuromuscular diseases. Chron Respir Dis, 2022; 19:14799731221094620.
42.
BartelsB, de GrootJF, HabetsLE, WadmanRI, AsselmanFL, NieuwenhuisEES, et al. Correlates of fatigability in patients with spinal muscular atrophy. Neurology, 2021; 96(6):e845-52-e852.
43.
KulnikST, LewkoA, MacbeanV, SpinouA. Accuracy in the assessment of cough peak flow: good progress for a “work in progress.” Respir Care, 2020; 65(1):133-134.
44.
ViswanathanM, AnsariMT, BerkmanNDN, ChangS, HartlingL, McPheetersM, et al. Assessing the risk of bias of individual studies in systematic reviews of health care interventions. In: Methods guide for effectiveness and comparative effectiveness reviews. Rockville, MD: Agency for Healthcare Research and Quality; 2008.
45.
AugerC, HernandoV, GalmicheH. Use of mechanical insufflation-exsufflation devices for airway clearance in subjects with neuromuscular disease. Respir Care, 2017; 62(2):236-245.
